Live from the NIH registry
Studies recruiting near Spokane right now
Top 25 of 292 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
Providence Medical Research Center — Spokane, Washington (0.5 mi)
· Sponsor: University of Michigan
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Medical Oncology Associates /ID# 247003 — Spokane, Washington (0.5 mi)
· Sponsor: AbbVie
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
Alcohol Use Disorder (AUD), Nicotine Use Disorder
Phase 2
Interventional 205 participants sought
Washington State University — Spokane, Washington (0.5 mi)
· Sponsor: Washington State University
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Cancer Care Northwest ( Site 0003) — Spokane, Washington (0.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Spokane, Washington (0.5 mi)
· Sponsor: Daiichi Sankyo
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Deaconess Hospital — Spokane, Washington (0.5 mi)
· Sponsor: Eli Lilly and Company
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Parkinson's Foundation PD GENEration Genetic Registry
Parkinson's Disease
N/A
Observational 35,382 participants sought
Inland Northwest Research — Spokane, Washington (0.5 mi)
· Sponsor: Parkinson's Foundation
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi)
· Sponsor: NRG Oncology
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Spokane, Washington (0.5 mi)
· Sponsor: Sameek Roychowdhury
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
NSCLC (Advanced Non-small Cell Lung Cancer), HNSCC
Phase 1
Interventional 170 participants sought
ALX Center 1 — Spokane, Washington (0.5 mi)
· Sponsor: ALX Oncology Inc.
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi)
· Sponsor: NRG Oncology
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
ERP to Improve Functioning in Veterans With OCD
Obsessive Compulsive Disorder (OCD), Comorbid Post-Traumatic Stress Disorder and OCD
N/A
Interventional 160 participants sought
Spokane VA Medical Center, Spokane, WA — Spokane, Washington (0.5 mi)
· Sponsor: VA Office of Research and Development
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
Solid Tumor, Biliary Tract Cancer
Phase 1, Phase 2
Interventional 140 participants sought
Medical Oncology — Spokane, Washington (0.5 mi)
· Sponsor: TiumBio Co., Ltd.
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Spokane, WA Investigative Site 10123 — Spokane, Washington (0.5 mi)
· Sponsor: Colorado Prevention Center
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Providence Sacred Heart Medical Center and Children's Hospital — Spokane, Washington (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Providence Sacred Heart Medical Center and Children's Hospital — Spokane, Washington (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi)
· Sponsor: SWOG Cancer Research Network
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Thompson's O&P — Spokane, Washington (0.5 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
Medical Oncology Associates — Spokane, Washington (0.5 mi)
· Sponsor: Gilead Sciences
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
Amblyopia
Phase 3
Interventional 252 participants sought
Spokane Eye Clinical Research — Spokane, Washington (0.5 mi)
· Sponsor: Jaeb Center for Health Research
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Psoriatic Arthritis
Phase 3
Interventional 1,088 participants sought
Arthritis Northwest, PLLC | Spokane, WA — Spokane, Washington (0.5 mi)
· Sponsor: Takeda
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Phase 3
Interventional 366 participants sought
Local Institution - 0264 — Spokane, Washington (0.5 mi)
· Sponsor: Bristol-Myers Squibb